T-Lymphocytes Genetically Targeted to the B-Cell Specific Antigen CD19 in Pediatric and Young Adult Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
Clinical trial NCT01860937 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01860937
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2027-05-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.